Home » Topics » Regulatory

Regulatory
RSS

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Sep. 8, 2000

Combination approved for second-line treatment of hypertension

Sep. 8, 2000

Phase I trial of TOBI in ventilator-associated pneumonia initiated

Sep. 8, 2000

Bone Care launches Hectorol Injection

Sep. 7, 2000

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Sep. 7, 2000

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...